12 Health Care Stocks Moving In Thursday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Thursday's after-market session, several healthcare stocks showed significant movement due to their Q1 earnings reports. Sensus Healthcare, TELA Bio, CareDx, Natera, Sharecare, and ADMA Biologics were among the gainers, with Sensus Healthcare leading with a 33.3% increase. On the downside, Macrogenics experienced the largest drop, falling 55.6%, followed by Progyny, Aesthetic Medical Intl, Clearside Biomedical, eFFECTOR Therapeutics, and Monopar Therapeutics.
May 09, 2024 | 8:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
ADMA Biologics shares increased by 9.23% to $7.57, with a market cap of $1.7 billion, after their Q1 earnings report.
The positive movement in ADMA Biologics' stock price following Q1 earnings indicates favorable investor sentiment towards the company's financial health.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
CareDx stock rose 13.01% to $12.5, with a market cap of $650.1 million, after announcing Q1 earnings.
The increase in CareDx's stock price post-Q1 earnings indicates positive investor response to the company's financial performance.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Natera's stock increased by 12.42% to $107.5, with a market cap of $13.1 billion, following their Q1 earnings.
Natera's stock price gain post-Q1 earnings suggests strong financial performance or positive future outlook, attracting investor interest.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Sensus Healthcare shares surged 33.3% to $5.08 after their Q1 earnings report, with a market value of $83.2 million.
The significant rise in Sensus Healthcare's stock price is directly attributed to its Q1 earnings report, indicating strong performance or positive investor sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
TELA Bio's shares increased by 13.36% to $5.6, with a market cap of $138.0 million, following their Q1 earnings release.
TELA Bio's positive stock movement is likely due to favorable Q1 earnings, reflecting investor optimism.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Macrogenics stock fell sharply by 55.6% to $6.51 following their Q1 earnings announcement, with a market cap of $407.2 million.
The drastic decline in Macrogenics' stock price post-Q1 earnings suggests negative results or outlook, significantly impacting investor confidence.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90